|
Volumn 45, Issue 9, 2010, Pages 4339-4342
|
New substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: In vitro and docking experiments
|
Author keywords
4 arylaminoquinazolines; Breast cancer; In vitro inhibition; Molecular docking
|
Indexed keywords
4 ARYLAMINOQUINAZOLINE;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
ERLOTINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER INHIBITION;
CANCER RESEARCH;
CELL PROLIFERATION;
CLINICAL EVALUATION;
COLON CANCER;
CYTOTOXICITY TEST;
DRUG DESIGN;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
KIDNEY CANCER;
LEUKEMIA;
LUNG NON SMALL CELL CANCER;
MELANOMA;
MOLECULAR DOCKING;
OVARY CANCER;
PROSTATE CANCER;
TUMOR CELL LINE;
BREAST NEOPLASMS;
CELL LINE, TUMOR;
HUMANS;
MODELS, MOLECULAR;
PROTEIN CONFORMATION;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 77955550330
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2010.04.034 Document Type: Article |
Times cited : (14)
|
References (30)
|